Alveo Technologies

📍 Alameda, United States🗓 Founded 2015👥 66 employees💰 Last funded Jan 2015
Biotechnology Research🌐 alveotechnologies.com
Website LinkedIn
Alveo Technologies is the first company to make molecular detection and diagnostics universally accessible – on the farm, in the field, in the clinic, or in the manufacturing plant – helping prevent or significantly limit the destructive impact of viruses, fungi, bacteria, and other pathogens by detecting earlier at the Point of Need™. Alveo’s portable, multiplex-capable diagnostic platform employs a patented method of direct electrical sensing of nucleic acid amplification to provide affordable, rapid, and accurate results. By enabling early pathogen detection, Alveo helps manage global health, food security, and supply chain resiliency by providing actionable insights at light speed. Know Sooner, Act Faster™ with Alveo. For more, visit: https://www.alveotechnologies.com/
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Alveo Technologies?
Alveo Technologies has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Alveo Technologies last raise funding?
The most recent investment in Alveo Technologies recorded on gritt.io was in January 2015.
When was Alveo Technologies founded?
Alveo Technologies was founded in 2015.
What industry is Alveo Technologies in?
Alveo Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alveo Technologies based?
Alveo Technologies is headquartered in Alameda, United States.